Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inpatients | 14 | 2024 | 678 | 2.520 |
Why?
|
| Rehabilitation Centers | 10 | 2023 | 83 | 1.740 |
Why?
|
| Neoplasms | 33 | 2024 | 15193 | 1.560 |
Why?
|
| Patient Transfer | 3 | 2017 | 137 | 1.330 |
Why?
|
| Disability Evaluation | 5 | 2018 | 249 | 1.180 |
Why?
|
| Physical and Rehabilitation Medicine | 2 | 2017 | 46 | 1.140 |
Why?
|
| Meningeal Neoplasms | 2 | 2021 | 441 | 1.090 |
Why?
|
| Fatigue | 4 | 2021 | 1239 | 0.940 |
Why?
|
| Phenol | 2 | 2013 | 19 | 0.920 |
Why?
|
| Cancer Survivors | 6 | 2021 | 650 | 0.920 |
Why?
|
| Rehabilitation | 3 | 2019 | 46 | 0.900 |
Why?
|
| Hospitalization | 11 | 2024 | 2083 | 0.900 |
Why?
|
| Physical Therapy Modalities | 3 | 2017 | 95 | 0.820 |
Why?
|
| Physiatrists | 2 | 2020 | 9 | 0.790 |
Why?
|
| Nerve Block | 2 | 2013 | 176 | 0.790 |
Why?
|
| Cancer Care Facilities | 5 | 2017 | 884 | 0.730 |
Why?
|
| Terminal Care | 2 | 2015 | 447 | 0.700 |
Why?
|
| Spinal Cord Compression | 1 | 2020 | 151 | 0.660 |
Why?
|
| Postural Balance | 4 | 2021 | 151 | 0.660 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2022 | 444 | 0.640 |
Why?
|
| Insurance, Disability | 1 | 2017 | 3 | 0.620 |
Why?
|
| Exercise | 5 | 2021 | 1183 | 0.620 |
Why?
|
| Delphi Technique | 2 | 2022 | 210 | 0.600 |
Why?
|
| Rehabilitation Research | 1 | 2016 | 3 | 0.600 |
Why?
|
| Pelvic Exenteration | 1 | 2017 | 108 | 0.590 |
Why?
|
| Paraneoplastic Syndromes, Nervous System | 1 | 2016 | 7 | 0.580 |
Why?
|
| Stiff-Person Syndrome | 1 | 2016 | 11 | 0.570 |
Why?
|
| Thrombocytopenia | 2 | 2020 | 846 | 0.570 |
Why?
|
| Knee | 2 | 2018 | 33 | 0.560 |
Why?
|
| Insurance Carriers | 1 | 2016 | 15 | 0.550 |
Why?
|
| Muscle Spasticity | 2 | 2013 | 74 | 0.540 |
Why?
|
| Pain | 2 | 2015 | 1658 | 0.540 |
Why?
|
| Graft vs Host Disease | 2 | 2024 | 2638 | 0.540 |
Why?
|
| Palliative Care | 5 | 2018 | 2037 | 0.530 |
Why?
|
| Paraneoplastic Cerebellar Degeneration | 1 | 2014 | 4 | 0.500 |
Why?
|
| Retrospective Studies | 23 | 2023 | 37905 | 0.500 |
Why?
|
| Spinal Neoplasms | 1 | 2020 | 631 | 0.500 |
Why?
|
| Patient-Centered Care | 2 | 2017 | 294 | 0.490 |
Why?
|
| Glioblastoma | 2 | 2023 | 1797 | 0.480 |
Why?
|
| Exercise Therapy | 4 | 2022 | 288 | 0.470 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2024 | 6550 | 0.470 |
Why?
|
| Hemorrhage | 1 | 2018 | 712 | 0.450 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2021 | 544 | 0.440 |
Why?
|
| Humans | 62 | 2024 | 261506 | 0.440 |
Why?
|
| Quality of Life | 10 | 2021 | 4532 | 0.430 |
Why?
|
| Brain Neoplasms | 4 | 2021 | 4849 | 0.430 |
Why?
|
| Botulinum Toxins | 1 | 2013 | 129 | 0.410 |
Why?
|
| Activities of Daily Living | 5 | 2020 | 552 | 0.410 |
Why?
|
| Length of Stay | 7 | 2019 | 1900 | 0.400 |
Why?
|
| Hematologic Neoplasms | 2 | 2020 | 1870 | 0.370 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2012 | 185 | 0.360 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 545 | 0.360 |
Why?
|
| Physical Exertion | 2 | 2020 | 113 | 0.350 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 1390 | 0.340 |
Why?
|
| Female | 32 | 2022 | 141928 | 0.330 |
Why?
|
| Middle Aged | 24 | 2021 | 86204 | 0.330 |
Why?
|
| Stem Cell Transplantation | 1 | 2015 | 1360 | 0.320 |
Why?
|
| Practice Guidelines as Topic | 2 | 2018 | 2403 | 0.310 |
Why?
|
| Multiple Myeloma | 2 | 2017 | 2138 | 0.310 |
Why?
|
| Intensive Care Units | 1 | 2012 | 717 | 0.310 |
Why?
|
| Astrocytoma | 1 | 2010 | 321 | 0.300 |
Why?
|
| Leukemia | 2 | 2013 | 1635 | 0.300 |
Why?
|
| Muscle Strength | 4 | 2021 | 104 | 0.300 |
Why?
|
| Male | 29 | 2022 | 123000 | 0.300 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 1581 | 0.300 |
Why?
|
| Aged | 17 | 2021 | 70117 | 0.260 |
Why?
|
| Fellowships and Scholarships | 2 | 2019 | 390 | 0.250 |
Why?
|
| Recovery of Function | 5 | 2020 | 703 | 0.250 |
Why?
|
| Healthy Volunteers | 2 | 2021 | 187 | 0.230 |
Why?
|
| Breast Neoplasms | 3 | 2019 | 15694 | 0.230 |
Why?
|
| Carcinoma | 1 | 2014 | 2578 | 0.220 |
Why?
|
| Movement | 2 | 2020 | 556 | 0.210 |
Why?
|
| Attitude of Health Personnel | 2 | 2019 | 918 | 0.210 |
Why?
|
| Platelet Count | 2 | 2013 | 490 | 0.200 |
Why?
|
| Electromyography | 1 | 2022 | 226 | 0.200 |
Why?
|
| Motivation | 2 | 2021 | 499 | 0.190 |
Why?
|
| Injections, Spinal | 1 | 2021 | 257 | 0.190 |
Why?
|
| Methylprednisolone | 1 | 2021 | 193 | 0.190 |
Why?
|
| Muscle Weakness | 1 | 2021 | 116 | 0.180 |
Why?
|
| Weight-Bearing | 1 | 2020 | 68 | 0.180 |
Why?
|
| Treatment Outcome | 8 | 2020 | 32848 | 0.180 |
Why?
|
| Fractures, Spontaneous | 1 | 2020 | 84 | 0.170 |
Why?
|
| Exercise Test | 1 | 2020 | 312 | 0.170 |
Why?
|
| Joint Instability | 1 | 2020 | 88 | 0.170 |
Why?
|
| Primary Health Care | 2 | 2017 | 787 | 0.170 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2022 | 799 | 0.170 |
Why?
|
| Posture | 1 | 2020 | 215 | 0.170 |
Why?
|
| Compression Bandages | 1 | 2018 | 10 | 0.170 |
Why?
|
| Referral and Consultation | 3 | 2023 | 899 | 0.170 |
Why?
|
| Patient Selection | 2 | 2017 | 2055 | 0.170 |
Why?
|
| Spinal Fractures | 1 | 2020 | 132 | 0.170 |
Why?
|
| Resistance Training | 1 | 2019 | 42 | 0.160 |
Why?
|
| Accidental Falls | 2 | 2018 | 142 | 0.160 |
Why?
|
| Spine | 1 | 2020 | 293 | 0.160 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 4638 | 0.160 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 17 | 0.160 |
Why?
|
| Consumer Health Information | 1 | 2018 | 52 | 0.160 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2018 | 211 | 0.160 |
Why?
|
| Adult | 16 | 2023 | 77950 | 0.150 |
Why?
|
| Oncologists | 1 | 2020 | 134 | 0.150 |
Why?
|
| Return to Work | 1 | 2017 | 17 | 0.150 |
Why?
|
| Ethics Consultation | 1 | 2017 | 31 | 0.150 |
Why?
|
| Culturally Competent Care | 1 | 2017 | 42 | 0.150 |
Why?
|
| Subacute Care | 1 | 2017 | 11 | 0.150 |
Why?
|
| Social Participation | 1 | 2016 | 20 | 0.150 |
Why?
|
| Hospice Care | 1 | 2018 | 156 | 0.150 |
Why?
|
| Public Health Surveillance | 1 | 2016 | 63 | 0.150 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 280 | 0.150 |
Why?
|
| Risk Assessment | 3 | 2023 | 6869 | 0.150 |
Why?
|
| Time and Motion Studies | 3 | 2021 | 43 | 0.150 |
Why?
|
| Antifungal Agents | 2 | 2013 | 834 | 0.140 |
Why?
|
| Critical Care | 1 | 2023 | 770 | 0.140 |
Why?
|
| Survivors | 3 | 2021 | 1031 | 0.140 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 29902 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2022 | 787 | 0.140 |
Why?
|
| Lower Extremity | 1 | 2018 | 299 | 0.130 |
Why?
|
| Hand Strength | 3 | 2021 | 65 | 0.130 |
Why?
|
| Prognosis | 5 | 2021 | 21713 | 0.130 |
Why?
|
| Logistic Models | 2 | 2013 | 3441 | 0.130 |
Why?
|
| Antiviral Agents | 2 | 2013 | 1230 | 0.130 |
Why?
|
| Lymphedema | 1 | 2018 | 239 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 1085 | 0.130 |
Why?
|
| Geriatric Assessment | 1 | 2016 | 275 | 0.130 |
Why?
|
| Speech Therapy | 1 | 2014 | 12 | 0.130 |
Why?
|
| Lymphoma | 2 | 2013 | 1467 | 0.120 |
Why?
|
| Occupational Therapy | 1 | 2014 | 46 | 0.120 |
Why?
|
| Internet | 1 | 2018 | 706 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2019 | 795 | 0.110 |
Why?
|
| Injections, Intramuscular | 1 | 2013 | 255 | 0.110 |
Why?
|
| Rare Diseases | 1 | 2016 | 351 | 0.110 |
Why?
|
| Communication | 1 | 2020 | 876 | 0.110 |
Why?
|
| Curriculum | 1 | 2018 | 860 | 0.110 |
Why?
|
| Venous Thromboembolism | 1 | 2017 | 335 | 0.110 |
Why?
|
| Hospital Units | 1 | 2012 | 38 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2017 | 600 | 0.110 |
Why?
|
| Injections | 1 | 2012 | 285 | 0.100 |
Why?
|
| Quality of Health Care | 1 | 2016 | 621 | 0.100 |
Why?
|
| Neuromuscular Agents | 1 | 2012 | 84 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 11538 | 0.100 |
Why?
|
| Leukocyte Count | 1 | 2013 | 684 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 4971 | 0.100 |
Why?
|
| Patient Discharge | 1 | 2016 | 661 | 0.100 |
Why?
|
| Hemipelvectomy | 1 | 2011 | 40 | 0.100 |
Why?
|
| Caregivers | 1 | 2017 | 677 | 0.100 |
Why?
|
| Genital Neoplasms, Female | 1 | 2017 | 735 | 0.100 |
Why?
|
| Comprehensive Health Care | 1 | 2011 | 49 | 0.090 |
Why?
|
| Mass Screening | 1 | 2019 | 1509 | 0.090 |
Why?
|
| Creatinine | 1 | 2012 | 531 | 0.090 |
Why?
|
| United States | 8 | 2021 | 15433 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2020 | 1763 | 0.090 |
Why?
|
| Blast Crisis | 1 | 2013 | 557 | 0.090 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 189 | 0.090 |
Why?
|
| Patient Readmission | 1 | 2013 | 548 | 0.090 |
Why?
|
| Incidence | 2 | 2017 | 5673 | 0.090 |
Why?
|
| Risk Factors | 3 | 2023 | 17523 | 0.080 |
Why?
|
| Cohort Studies | 2 | 2021 | 9244 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2013 | 1274 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2013 | 1171 | 0.070 |
Why?
|
| Survival Rate | 2 | 2017 | 12221 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2015 | 10035 | 0.070 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1148 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2010 | 739 | 0.070 |
Why?
|
| Young Adult | 3 | 2013 | 21445 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2017 | 9180 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2021 | 12873 | 0.060 |
Why?
|
| Glioma | 1 | 2016 | 1963 | 0.060 |
Why?
|
| Cognition | 1 | 2010 | 968 | 0.060 |
Why?
|
| Surveys and Questionnaires | 3 | 2022 | 5687 | 0.060 |
Why?
|
| Walk Test | 1 | 2021 | 43 | 0.050 |
Why?
|
| Facial Pain | 1 | 2020 | 20 | 0.050 |
Why?
|
| Algorithms | 2 | 2022 | 3890 | 0.050 |
Why?
|
| Time Factors | 1 | 2014 | 12926 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 2992 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2020 | 401 | 0.040 |
Why?
|
| Capacity Building | 1 | 2018 | 30 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 15862 | 0.040 |
Why?
|
| Knee Joint | 1 | 2019 | 161 | 0.040 |
Why?
|
| Survivorship | 1 | 2018 | 109 | 0.040 |
Why?
|
| Specialization | 1 | 2018 | 130 | 0.040 |
Why?
|
| Heart Rate | 1 | 2020 | 737 | 0.040 |
Why?
|
| Adolescent | 3 | 2019 | 31252 | 0.040 |
Why?
|
| American Heart Association | 1 | 2019 | 310 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 350 | 0.040 |
Why?
|
| Medicare | 1 | 2021 | 860 | 0.030 |
Why?
|
| Health Policy | 1 | 2018 | 291 | 0.030 |
Why?
|
| Self Care | 1 | 2017 | 224 | 0.030 |
Why?
|
| Consensus | 1 | 2019 | 978 | 0.030 |
Why?
|
| Patient Care Planning | 1 | 2015 | 297 | 0.030 |
Why?
|
| Child | 2 | 2011 | 29154 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 2803 | 0.030 |
Why?
|
| Recurrence | 1 | 2020 | 4758 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2019 | 1270 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2015 | 764 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 2352 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 1303 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 6100 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 1323 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2011 | 953 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 14889 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2011 | 5542 | 0.010 |
Why?
|